Who owns Lexicon Pharmaceuticals?

Key details on Lexicon Pharmaceuticals (Ticker: LXRX)

Who owns Lexicon Pharmaceuticals?

Is LXRX a good stock to own? Find out who bought Lexicon Pharmaceuticals, who sold Lexicon Pharmaceuticals (LXRX) stock, and who holds a large position in Lexicon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Artal Group S.A. 253.37M $603.03M Sept. 30, 2013
FMR 77.07M $133.33M March 31, 2014
Ulys 29.78M $51.52M March 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 18.99M $32.47M March 31, 2014
Vanguard 13.96M $24.15M March 31, 2014
BlackRock Fund Advisors 12.08M $20.90M March 31, 2014
NEA Management Company 11.68M $20.20M March 31, 2014
STATE STREET CORPORATION 7.62M $13.18M March 31, 2014
BlackRock Institutional Trust Company, N.A. 7.34M $12.69M March 31, 2014
T. Rowe Price Associates 6.45M $11.17M March 31, 2014
Royce & Associates 4.23M $7.32M March 31, 2014
Invus Public Equities Advisors 3.89M $6.85M June 30, 2011
Schroder Investment Management 3.24M $5.61M March 31, 2014
Perceptive Advisors 3.20M $6.97M March 31, 2013
NORTHERN TRUST 2.96M $5.12M March 31, 2014
JPMORGAN CHASE & CO 2.92M $6.57M June 30, 2012
Jefferies 2.13M $3.80M Dec. 31, 2013
Franklin Resources 2.11M $5.00M Sept. 30, 2013
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 2.08M $3.35M June 30, 2014
Gabelli Funds 1.83M $3.29M Dec. 31, 2013
Geode Capital Management 1.72M $2.98M March 31, 2014
Allianz Asset Management AG 1.68M $3.64M June 30, 2013

Who sold Lexicon Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.54M $4.57M